Stay updated on Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label changed from v3.6.4 to v3.6.5, indicating a minor update to the listing without modifying the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a minor maintenance update to the study page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAdded a new page revision entry: v3.6.3, replacing the prior v3.6.2. It reflects a minor update to the study record on ClinicalTrials.gov and does not change the study details or eligibility.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a new version of the page.SummaryDifference0.1%

- Check58 days agoChange DetectedEnrollment status shows no longer looking for participants, indicating recruitment has ended. New help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) are added, and the Intervention/Treatment heading formatting is updated, with a revision note showing Revision: v3.6.0.SummaryDifference0.4%

- Check65 days agoChange DetectedThe study page now shows revision v3.5.5 instead of v3.5.4, signaling a recent update to the record.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.